Expression, purification and functional validation of a cancer-associated isoform of the HBx protein from human hepatitis B virus

The human hepatitis B virus (HBV) causes hepatitis B, a liver infection that can be acute or chronic. HBV encodes four proteins, among which the X protein (HBx) plays a critical role in viral replication. During chronic HBV infection, in which the viral DNA is integrated into the host genome, the HB...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Clavier, Alexis (VerfasserIn) , Gómez-Evain, Santiago (VerfasserIn) , Shida, Toshinobu (VerfasserIn) , Abanti, Rubaba R. (VerfasserIn) , Hammerstein, Franziska (VerfasserIn) , Kielkowski, Pavel (VerfasserIn) , Leuthold, Mila (VerfasserIn) , Schütz, Anne (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 2026
In: Protein expression and purification
Year: 2026, Jahrgang: 238, Pages: 1-7
ISSN:1096-0279
DOI:10.1016/j.pep.2025.106842
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.pep.2025.106842
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S1046592825001846
Volltext
Verfasserangaben:Alexis Clavier, Santiago Gómez-Evain, Toshinobu Shida, Rubaba R. Abanti, Franziska Hammerstein, Pavel Kielkowski, Mila Leuthold, Anne K. Schütz
Beschreibung
Zusammenfassung:The human hepatitis B virus (HBV) causes hepatitis B, a liver infection that can be acute or chronic. HBV encodes four proteins, among which the X protein (HBx) plays a critical role in viral replication. During chronic HBV infection, in which the viral DNA is integrated into the host genome, the HBx1-120 isoform, comprising the N-terminal 120 residues, is highly expressed. Here, we describe a protocol for the recombinant overexpression and purification of untagged HBx1-120 from bacterial cells. The procedure is compatible with stable isotope labelling in minimal media. Following cell lysis, HBx1-120 was recovered from inclusion bodies (IBs), solubilized in urea, and purified by ion-exchange (IEX) and size-exclusion chromatography (SEC). The purified protein was extensively characterized, including by mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy. Functionality was confirmed by a pulldown assay with a known interacting partner, Spindlin1. This protocol provides a robust framework to obtain untagged HBx1-120 for structural and functional in vitro studies.
Beschreibung:Online verfügbar: 03. November 2025, Artikelversion: 05. November 2025
Gesehen am 13.02.2026
Beschreibung:Online Resource
ISSN:1096-0279
DOI:10.1016/j.pep.2025.106842